Ademi LLP is investigating UniFirst (NYSE: UNF) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Universal Health Services.
In the transaction, UniFirst stockholders will receive $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share owned, based on Cintas’ closing price of $200.77 on March 9, 2026. The transaction is valued at approximately $5.5 billion
UniFirst insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for UniFirst by imposing a significant penalty if UniFirst accepts a competing bid. We are investigating the conduct of the UniFirst board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
Join this Action